During a pause in its appraisal by NICE the drug, palbociclib (Ibrance), is being made available to suitable secondary breast cancer patients. Our Clinical Nurse Specialist for Secondary Beast Cancer, Catherine Priestley explains more.
Nearly half of all hospitals are failing to provide specialist support for people living with secondary breast cancer. We spoke to Tracy, a secondary breast specialist cancer nurse, about the importance of providing support to women living with the condition.
We are very worried that upcoming government changes to the way drugs are made available on the NHS in England may reduce access to new treatments for people both with primary and secondary breast cancer. You can add your voice as we urge NHS England to act on these concerns.